AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DUTASTERIDE + TAMSULOSIN HYDROCHLORIDE

11 registrations across 4 African markets— 11 active

Markets with DUTASTERIDE + TAMSULOSIN HYDROCHLORIDE

Recent registrations

Brand / ProductMarketHolderStatusExpires
Tamsulosin Hydrochloride and Dutasteride Capsules_
Capsule
🇳🇬NigeriaEmbassy Pharmaceutical and Chemicals LimitedactiveOct 2030
Tamduster Tablets_
Tablet
🇳🇬NigeriaActivity Pharmaceutical Co. LtdactiveOct 2029
Tamsudart Capsules
Capsule
🇳🇬NigeriaEldoxa LtdactiveJan 2029
Flowel Plus Capsules
Capsule
🇳🇬NigeriaSuperior Pharmaceuticals LimitedactiveAug 2028
Co-Strimax
Tablet
🇳🇬NigeriaEvans Therapeutics LimitedactiveMay 2028
DUTAS-T CAPSULES
Capsule, Hard
🇰🇪KenyaQUESTA CARE INCactiveNov 2026
Duostam Tablets**
Tablet
🇳🇬NigeriaPharmacy Plus LtdactiveFeb 2026
Duodart Capsules**
Capsule
🇳🇬NigeriaGlaxoSmithKline Consumer Nigeria PLC (GSK)activeNov 2025
DUTASTERIDE + TAMSULOSIN HYDROCHLORIDE
ORAL SOLID ORDINARY CAPSULES
🇺🇬UgandaMEGA LIFESCIENCES PUBLIC COMPANY LTDactive
DUTASTERIDE + TAMSULOSIN HYDROCHLORIDE
ORAL SOLID ORDINARY CAPSULES
🇺🇬UgandaMEGA LIFESCIENCES PUBLIC COMPANY LTDactive
DUTABIT PLUS 0.5/0.4
Capsules
🇹🇿TanzaniaAurobindo Pharma Limitedactive

DUTASTERIDE + TAMSULOSIN HYDROCHLORIDE in Africa — Regulatory Overview

DUTASTERIDE + TAMSULOSIN HYDROCHLORIDE is registered across 4 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Nigeria, Uganda, Kenya, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.